- Home
- MAT vs RVMD Comparison
MAT vs RVMD Comparison
Compare MAT & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MAT | RVMD |
|---|---|---|
| Founded | 1945 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 7.5B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | MAT | RVMD |
|---|---|---|
| Price | $20.59 | $77.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 18 |
| Target Price | $24.00 | ★ $77.11 |
| AVG Volume (30 Days) | ★ 3.8M | 2.2M |
| Earning Date | 02-03-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | ★ $5,227,568,000.00 | N/A |
| Revenue This Year | $1.98 | N/A |
| Revenue Next Year | $3.54 | $714.50 |
| P/E Ratio | $15.27 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.95 | $29.17 |
| 52 Week High | $22.07 | $81.49 |
Technical Indicators
Market Signals| Indicator | MAT | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.91 | 68.01 |
| Support Level | $20.06 | $77.54 |
| Resistance Level | $21.38 | $80.44 |
| Average True Range (ATR) | 0.66 | 2.61 |
| MACD | -0.10 | -0.67 |
| Stochastic Oscillator | 46.27 | 57.21 |
Price Performance
Historical ComparisonAbout MAT Mattel Inc.
Mattel manufactures and markets toy products that are sold to its wholesale and direct to retail customers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, hand-held and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Nearly 60% of its net sales were generated from North America in 2024, with the remainder stemming from international markets.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.